This website uses cookies to ensure you get the best experience on our website. Learn more

Paul Bieniasz: SARS-CoV-2 Variants vs Antibodies: An Evolutionary Conflict

x
  • Science of COVID-19: “The neutralizing antibody response to SARS-CoV-2”

    1:15:41

    This week's speaker is Paul Bieniasz, an HHMI Investigator, professor, and head of the Laboratory of Retrovirology at The Rockefeller University.

    Paul Bieniasz seeks to define how host genes influence the replication of viruses, with an emphasis on human and primate immunodeficiency viruses. His lab tries to characterize the host functions that viruses mimic, manipulate, and otherwise exploit, as well as the defenses cells have evolved against viral infection. In addition to his work on modern viruses, Bieniasz has pioneered the field of “paleovirology,” which explores how ancient viruses impacted the evolution of their hosts. His lab also seeks to understand how ancient retroviruses were extinguished, which may give clues about how to combat modern viral infections. Bieniasz holds a PhD in virology from the University of London.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE: janelia.org/scienceofcovid19

  • x
  • Webinar: T Cells: A New Hope for Lasting Protection against SARS-CoV-2

    1:28:41

    Many immunologists are looking at T cells to understand the potential for lasting immunity to SARS-CoV-2. In this webinar, Drs. Alessandro Sette and Shane Crotty of La Jolla Institute for Immunology present their latest findings in T cell function following SARS-CoV-2 infection and the implications for vaccine development and lasting immune memory.

    Topics covered:
    1. CD4+ and CD8+ T cell recognition of SARS-CoV-2 sequences in unexposed individuals and potential cross-reactivity with common cold coronaviruses
    2. Implications of the T cell response against SARS-CoV-2 for vaccine design and viral escape
    3. How the nature of the acute immune response correlates with COVID-19 severity
    4. Factors affecting COVID-19 immune response duration and memory

  • x
  • Shane Crotty: Adaptive Immunity and Immune Memory to SARS-CoV-2 after COVID-19

    1:25:48

    This week's speaker is Shane Crotty, a professor at the Center for Infectious Disease and Vaccine Research at La Jolla Institute for Immunology.

    Crotty's team studies immunity against infectious diseases and investigates how the immune system remembers infections and vaccines. He is the author of Ahead of the Curve, a biography of scientist and Nobel laureate David Baltimore, published in 2001. He earned his BS in biology and writing from MIT and his PhD in molecular biology/virology from UCSF.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE: janelia.org/scienceofcovid19

  • Jason McLellan: Structure-based Design of Vaccine Antigens for SARS-CoV-2

    1:12:36

    This week's speaker is Jason S. McLellan, associate professor and Robert A. Welch Chair in Chemistry at the University of Texas at Austin.

    The McLellan Lab is interested in elucidating the molecular mechanisms of host–pathogen interactions, particularly those involving viral glycoproteins. For this research, the lab exploits the synergy that exists between basic and translational science. Namely, the determination of structures and the development of tools needed to answer basic science questions can be translated into therapeutic interventions, which in turn can be used as reagents to further illuminate biological processes.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE:

  • x
  • Science of COVID-19: Aerosolized Nanobodies for SARS-COV-2 Passive Immunization

    1:6:17

    Dr. Aashish Manglik's lab is focused on decoding the molecular basis of transmembrane signaling and transport. The particular systems we study lie at the intersection of human health and protein science.

    Organized by Loren Looger and Sarada Viswanathan, this seminar series brings in outside experts, covers papers & preprints, and highlights local efforts in testing, production, and analysis.

    Learn more at

  • Wondfo Serial Webinar 4—Neutralizing Antibody: Emerging Role In COVID-19 Pandemic

    1:11:40

    In Wondfo's EXPERT DIALOGUE serial webinar EP4 on 22nd July, Prof. Ashok Rattan and Dr. Bachti Alisjahbana were invited to share their insights and experience about the significances and the impacts that neutralizing antibody exerts on vaccination program and pandemic. Come and join us in sharing latest knowledge of NAb.

  • x
  • Science of COVID-19: The molecular biology of coronavirus infection.

    1:33:15

    Dr. Glaunsinger is an associate professor in the Department of Plant and Microbial Biology and in the Department of Molecular and Cell Biology at the University of California, Berkeley, and a member of the California Institute for Quantitative Biosciences (QB3).

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

  • Covid-19 Vaccine Immunity and the Impact of Variants

    47:02

    As the delta variant becomes the dominant strain of the Covid-19 pandemic, scientists are working to understand the role variants will play in future surges of Covid-19, the efficacy of current vaccines, and how long immunity will last. Dr. Shane Crotty,, virologist and professor in the Center for Infectious Disease and Vaccine Research at the La Jolla Institute for Immunology (LJI), provides insights on the progress of Covid-19 vaccine immunity research for current U.S. Covid-19 vaccines (Pfizer, Moderna, Janssen/Johnson & Johnson), and critical emerging questions, such as the impact of the delta variant on the efficacy of current Covid-19 vaccines.

  • Webinar COVID-19 II - parte 2 de 2

    1:29:55

    Modelo organizativo de contingência dos CSP/SNS
    Dr. Bernardo Vilas Boas, ARS Norte

  • x
  • Paul Bieniasz: SARS-CoV-2 Variants vs Antibodies: An Evolutionary Conflict

    1:29:39

    This week's speaker is Paul Bieniasz, an HHMI Investigator, professor, and head of the Laboratory of Retrovirology at The Rockefeller University.

    Bieniasz seeks to define how host genes influence the replication of viruses, with an emphasis on human and primate immunodeficiency viruses. His lab tries to characterize the host functions that viruses mimic, manipulate, and otherwise exploit, as well as the defenses cells have evolved against viral infection. In addition to his work on modern viruses, Bieniasz has pioneered the field of “paleovirology,” which explores how ancient viruses impacted the evolution of their hosts. His lab also seeks to understand how ancient retroviruses were extinguished, which may give clues about how to combat modern viral infections. Bieniasz holds a PhD in virology from the University of London.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE:

  • The COVID-19 Pandemic: Insights and Overview

    1:19:39

    Session 3 – Viruses and Vaccines. Paul Bieniasz, Ph.D., Professor and Head, Laboratory of Retrovirology at The Rockefeller University, and Investigator at the Howard Hughes Medical Institute delivers the third lecture in the 2021 Talking Science four-part webinar series, The COVID-19 Pandemic: Insights and Overview. This virtual event was recorded on February 8, 2021.

  • Zijun Wang, Virtual COVID-19 Symposium: March 17, 2021

    24:28

    Zijun Wang, PhD, Postdoctoral Associate, Michel C. Nussenzweig Lab, The Rockefeller University, mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

    Dr. Wang presented their newly published results regarding the neutralizing activity of mRNA vaccine-elicited antibodies to SARS-CoV2 and other variants. They found that the plasma neutralizing potential and memory B cell numbers of vaccinated volunteers were similar to those recovering from the infection, but the plasma activity against viral variants decreased slightly but significantly. However, the monoclonal antibodies' neutralizing activity elicited by the vaccines was reduced dramatically to the K417N, E484K, or N501Y mutant variants, although the vaccine-elicited monoclonal antibodies neutralized no-mutant SARS-CoV2 robustly. Because of the varied mutation locations in the receptor-binding domain (RBD), the viral variants were specifically resistant to a specific class of monoclonal antibodies. Hence, the antibody combinationswere still able to neutralize all the viral variants potently. In summary, the vaccine-elicited antibodies became weaker to neutralize several viral variants. With combination strategies or polyclonal antibodies, the vaccine-elicited antibody immunity was still protective. But we should appropriately update the clinical application of the monoclonalantibodies, or the vaccine design according to the viral variants.

  • Neville Sanjana: New frontiers in SARS-CoV-2 functional genomics

    1:9:13

    This week's speaker is Neville Sanjana, an assistant professor of biology at New York University.

    Neville Sanjana's research interests include bioengineering, genomics, neuroscience, cancer biology, and systems biology. His lab at NYU develops technologies to understand how human genetic variants cause diseases of the nervous system and cancer. Sanjana's team uses a multi-disciplinary approach, combining genome engineering, pooled genetic screens, bioinformatics, electrophysiology, and imaging, to dissect the inner workings of the human genome and its dysfunction in autism and tumor evolution. He holds a PhD in brain & cognitive sciences from MIT, as well as a BS in symbolic systems and a BA in English from Stanford University.

    Organized by Janelia's Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.

    LEARN MORE: janelia.org/scienceofcovid19

  • Dangerous differences of Delta variant | Connect the Dots

    1:40

    With case counts rising and hospitals filling up, a lot of you are wondering what makes this version of the virus so much worse?

  • Conversations About COVID, July 14, 2021

    46:06

    Origins and Evolution of SARS CoV2: What Have We Learned? Why Does It Matter?
    Dr. Laurel Hartley, Associate Professor, Department of Integrative Biology, CLAS, CU Denver

    Dr. Hartley’s research bridges community and ecosystem ecology to explore how plant communities and soils respond to external factors such as intensive herbivory, nutrient inputs, emerging infectious diseases, and climate change. The model system that she works on has shaped and integrated the questions that she pursues. She studies the impact of introduced bubonic plague on both urban and rural black-tailed prairie dog (Cynomys ludovicianus) communities. This field research involves mostly observational studies across space and time gradients.

  • Science Saturday Lecture: Viruses: Pirates of The Cell

    23:04

    Science Saturday
    May 4, 2019

    Grades 5–8 Lecture:
    Viruses: Pirates of The Cell

    Paul Bieniasz, Ph.D.
    Professor
    Laboratory of Retrovirology

  • The Viruscraft robot virus capsid running its spike protein test

    1:04

  • Dr. Klotmans Video Message - Week 72

    23:27

    Baylor College of Medicine's Dr. Paul Klotman addresses how people can protect themselves and reviews the latest data and science.

  • Vaccines Save 50 Million Lives, But COVID Threatens Future Gains, Say Scientists

    3:01

    Researchers warn access to life-saving vaccines against 10 infectious diseases has been hampered by pandemic

  • Science of COVID-19: NextStrain, Sequencing and the SARS-CoV-2 Pandemic

    1:9:41

    This week's speaker is Emma Hodcroft, a molecular epidemiologist at the University of Basel in Switzerland.

    Dr. Emma Hodcroft is a researcher at the University of Basel and the co-developer of NextStrain, an open-source toolkit built for real-time tracking of viral outbreaks. She has mostly focused on Enterovirus D68, a respiratory pathogen that primarily infects young children, but she is currently working full-time on SARS-CoV-2. Dr. Hodcroft has also worked on HIV and was part of the PANGEA-HIV initiative, funded by the Bill & Melinda Gates Foundation, aimed at using phylogenetics and molecular epidemiology to gain new understanding of the HIV epidemic in Sub-Saharan Africa. She holds an undergraduate degree from Texas Christian University, and a master's degree and PhD from the University of Edinburgh.

    Organized by Loren Looger and Sarada Viswanathan, this seminar series brings in outside experts, covers papers & preprints, and highlights local efforts in testing, production, and analysis.

  • x
  • CryoEM electron density map of DNA and histones

    1:32

    This cryoEM electron density map reveals DNA wound around histones in the giant virus Melbournevirus. Credit: Y. Liu et al./Cell 2021 Read more:

  • Antibodies Implication in Biotechnology with special emphasis on management of Covid-19 Pandemic.

    1:17:13

    The Medical Laboratory Technology unit of the School of Health Sciences is going to organize a Corporate Lecture.

  • Stephan Preibisch: “Reconstructing large-scale lightsheet microscopy acquisitions”

    53:16

    Stephan Preibisch, Team Lead, Computational Methods Development at HHMI's Janelia Research Campus.

    Abstract:
    Light-sheet microscopy is an emerging technology that allows the acquisition of developing samples like Drosophila or mouse embryos in their entirety, and recently also enables to image very large fixed samples such as adult mouse brains at single-cell resolution or even Drosophila larval brains with super-resolution. To cover entire samples, sets of tiled three-dimensional images can be acquired from different physical orientations while illuminating the sample from different directions.

    These image acquisitions amount to very large datasets in the terabyte range that require complex image reconstruction including image registration, correction of optical distortions arising from light refraction inside the sample, and deconvolution in order to create seamless datasets for downstream analysis (Fig. 1).

    We will present concepts and software that efficiently handles and interactively reconstructs such large multi-tile, multi-view acquisitions. These solutions automatically and efficiently align all image tiles, optionally compensate aberrations inside the sample using non-rigid image deformation, and fuse datasets using averaging strategies or deconvolution. Additionally, image resolution can be estimated in all parts of the reconstructed sample to confirm uniform, high-resolution acquisitions. The software is implemented as open-source based on ImgLib2, uses BigDataViewer and Spark, and large parts are available as Fiji plugins making high-resolution light-sheet microscopy acquisitions amenable to biological studies.

    We will additionally discuss new developments for data storage, handling of sheared volumes and visualization that will in the future to scale to up to peta-byte sized image acquisition.

    More information about Janelia’s Optical Interest Group can be found here:

  • Webinar - Covid-19 e a Diabetes

    1:14:14

  • How can Coronavirus Mutate and Which Species did it Originate from?

    11:59

    Welcome you all to “Executive corner - Expert talks - 20 mins Round up with Professor Nikolai Petrovsky .He is the Research Director of endocrinology at Flinders Medical Centre with a joint position as Professor of Medicine at Flinders University.
    He is also Vice President and Secretary General of the International Immunomics Society.  He works with Vaxine – that’s with an X - an internationally recognised vaccine research and development company that has made many global breakthroughs. 

    #flindersmedicalcentre #profNikolaiPetrovsky  #ResearchDirectorofendocrinology #InternationalImmunomicsSociety #kalkinemedia

    Kalkine TV is a one-stop solution to all the market-related nuances. The streaming platform offers in-depth and latest information on share market, commodities, crypto charter and economic developments. Kalkine TV leverages the expertise of in-house sector specialists, fundamental analysts and technical experts to touch base on hot trends driving the market charter and volatility.

    So, do tune in to Kalkine TV daily to catch live talk shows, market beats, and sector analysis.

    To get more updates about Australia, NZ, UK, Canada and US stock market news, investors education & insights, subscribe our channel at

    Check out our media Website ????
    Follow us and stay updated on the Go with the Market Charter ????????
    Facebook -
    Twitter -
    LinkedIn -

  • #EU2021PT: Health Challenges in Post-Covid-19 World

    4:21:13

    Sledujte další z cyklu konferencí při příležitosti portugalského předsednictví Rady EU.

    Konference je v angličtině, netlumočená.

    POPIS / DESCRIPTION
    Strategic investment in health infrastructures and innovation in the health industry became even more relevant as a consequence of the COVID-19 pandemic. Indeed, this crisis represented an unprecedented challenge to the management and response to public health crises on a global scale and made even more urgent a wider discussion about what is working and what needs to be improved.

    The PPEU will aim to promote enhanced cooperation between Member States in the health department by supporting the necessary actions to increase the responsiveness of services related to public health threats, and by supporting Member States’ efforts to produce and distribute a safe and accessible vaccine throughout Europe and the rest of the world.

    Therefore, this conference aims to contribute to the debate about strategic investment in health infrastructures and innovation in the health industry in the world and, especially, in the European Union. It is intended not only to equate what has been done so far, but also to raise new conclusions on what still lacks for a sufficient and efficient approach.

    PROGRAM / PROGRAMME

    13:00–14:00

    WELCOME ADDRESS AND INTRODUCTORY REMARKS
    – Luís de Almeida Sampaio, Ambassador of Portugal in the Czech Republic
    – Lilyana Pavlova, Vice-President, European Investment Bank, Luxembourg
    – John Ryan, Director for Public Health, DG SANTE, European Commission

    KEYNOTE CONVERSATION
    – Helena Rögnerová, Deputy Minister, Ministry of Health of the Czech Republic
    – Maria de Belém Roseira, former Minister of Health of Portugal
    – Adalberto Campos Fernandes, former Minister of Health of Portugal

    Chaired by Luís de Almeida Sampaio, Ambassador of Portugal in the Czech Republic.

    14:00–15:30

    PANEL I: Health challenges in a post Covid world

    – John Ryan, Director for Public Health, DG SANTE, European Commission
    – Filipe Froes, Head of Intensive Care Unit of Hospital Pulido Valente, Portugal
    – Miguel Mouras Guedes, Head of Department of Neurosurgery, Portugal
    – Fausto Pinto, Dean Faculty of Medicine, University of Lisbon
    – Martin Vokurka, Head of the Institute of Pathological Physiology, Dean of the 1st Faculty of Medicine, Charles University, Prague
    – Peter Widimský, Dean of the 3rd Faculty of Medicine, Charles University, Prague

    Chaired by Srdan Matić, Head of the Czech Branch of the World Health Organization.

    15:30–17:00

    PANEL II: Strategic Investments in Health Infrastructure & Innovations in the Health Industry

    – Felicitas Riedl, Head of division Life Science and Health, European Investment Bank, Luxembourg
    – Carlos Martins, former State Secretary for Health of Portugal
    – Jiří Malý, Deputy Director, CMO, Institute for Clinical and Experimental Medicine IKEM
    – Jakub Dvořáček, Director of The Association of Innovative Pharmaceutical Industry CR
    – Vladimír Komárek, Dean of the 2nd Faculty of Medicine, Charles University, Prague

    Chaired by Nathalie Binet, Head of the EIB Group office in Prague.

  • Welcome To Cell Biology Fall 2018

    14:56

  • CS 182: Lecture 19: Part 3: GANs

    27:31

  • Um ano de COVID-19 ou o bom, o mau e o vilão | webinar 2

    1:6:11

    Filipe Froes | Membro no Conselho Nacional de Saúde Pública
    António Rendas | Membro do Conselho Consultivo CUF

  • COVID-19 Webinar - 23 Março 2020

    1:13:30

    COVID-19 - Learning with the Italian Experience.
    Com o Dr. Tommaso Mauri, Professor José Artur Paiva, Dr. João Gouveia e Dr. Filipe Froes.

  • Influenza vaccination - Prof Filipe Froes

    3:14

    Professor Froes (Lisboa, Portugal) tackles three major topics regarding influenza: the burden of influenza disease, the role of influenza annual vaccination and what we can do to increase influenza vaccination rates.
    To learn more, visit

  • Rethinking Global Health - Building back better after Covid-19

    3:12:26

    Diskutiert live mit auf Twitter und stellt eure Fragen mit dem Hashtag #rethinkingglobalhealth!

    Die Covid-19-Pandemie ist in ihrem Ausmaß und ihren Auswirkungen beispiellos. Innerhalb weniger Wochen hat sich die Pandemie auf allen Kontinenten ausgebreitet und zur größten globalen Krise seit dem 2. Weltkrieg geführt. Die Funktionsfähigkeit unserer Regierungen, der Gesundheitssysteme und internationalen Organisationen sind nun auf den Prüfstand gestellt - nicht alle Ergebnisse werden zufriedenstellend sein. Fakt ist, dass das Coronavirus die Welt verändert hat und weiterhin verändern wird. Während die kurzfristigen Auswirkungen bereits offensichtlich sind, sind die langfristigen Folgen der Pandemie schwer abzuschätzen.
    Für eine wirklich transformative Erholung von Covid-19 müssen wir die globale Gesundheit überdenken, um das Risiko künftiger Krisen zu verringern und die Ziele der Agenda 2030 zu erreichen. Daher werden wir die Diskussion über die aktuelle Pandemie erweitern und ihre langfristigen Auswirkungen auf die internationale Ordnung, die Arbeit der Vereinten Nationen und der globalen Gesundheitsinstitutionen besprechen. Wir werden über neue, innovative Strategien diskutieren, um alle Akteure einzubinden, die Pandemievorsorge zu verbessern und die Umsetzung der Ziele der Agenda 2030 zu beschleunigen. Das ultimative Ziel dieser Konferenz ist es, zu einer ehrgeizigen Reformagenda beizutragen, um eine sicherere und gesündere Zukunft nach der Pandemie für alle zu schaffen.


    Programm

    17:00  Begrüßung
    Michael Theurer MdB, Stellv. Fraktionsvorsitzender
    Keynote
    Susan Bergner, Wissenschaftlerin, Stiftung Wissenschaft und Politik

    17:20 Managing Pandemics
    Dr. Bernhard Schwartländer, WHO Kabinettschef
     Dr. Christoph Benn, Direktor für Globale Gesundheitsdiplomatie, Joep Lange Institut
    Caroline Schmutte, Leiterin des deutschen Büros des Wellcome Trust
    Dr. Ricardo Baptista Leite, Präsident und Gründer von UNITE Global Parlamentarian Network to End Infectious Diseases
    Prof. Dr. Andrew Ullmann MdB
    Moderation: Maike Voss, Wissenschaftlerin, Stiftung Wissenschaft und

    18:20 Politik Pandemic Prepardeness: Building stronger partnerships
    Birgit Pickel, Unterabteilungsleiterin bei Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung
    Dr. Catharina Boehme, CEO, Foundation for Innovative New Diagnostics
    Roland Göhde, Vorstandsvorsitzender German Health Alliance
    Dianne Stewart, Abteilungsleiterin beim Globalen Fonds zur Bekämpfung von Aids,
    Tuberkulose und Malaria (tbc)
    Prof. Dr. Dr. Andrew Ullmann MdB
    Moderation: Maike Voss, Wissenschaftlerin, Stiftung Wissenschaft und Politik

    19:15 Schlussworte
    Ulrich Lechte MdB und Prof. Dr. Andrew Ullmann MdB



    _________________________________________________

    Abonniert den Kanal für Updates zu neuen Videos:

    Folgt der Fraktion auf Facebook:
    oder Twitter:
    oder Instagram:

  • Webinar COVID-19 Grupos de risco e comorbilidades

    1:55:47

    Doentes com diabetes, com doença renal, com patologias cardiovasculares, com neoplasias e com doenças respiratórias têm sido apontados como grupos de risco para o desenvolvimento de complicações associadas ao novo coronavírus. Mas que cuidados devem reforçar para se protegerem da COVID-19?
    Acompanhe em boehringer-webinars.pt

  • CERIMÓNIA PRÉMIO BIAL DE MEDICINA CLÍNICA 2020 - FILIPE FROES

    2:53

  • #UEpósCOVID - Filipe Froes

    2:03

    Desafiámos várias figuras públicas e opinion makers a partilharem nos seus canais digitais uma mensagem sobre como projetam a Europa do pós-pandemia covid19 numa mensagem de vídeo.

    Durante o Dia da Europa convidamo-lo a pesquisar os vários depoimentos com #UEpósCOVID e a descobrir as várias personalidades que se juntaram a esta iniciativa. E porque a sua voz também conta, não deixe de partilhar a sua visão sobre o futuro do projeto europeu com #UEpósCOVID.

  • Sandra Pereira questiona os Professores Baltazar Nunes e Filipe Froes

    2:41

    Intervenção na Comissão Eventual para o acompanhamento da aplicação das medidas de resposta à pandemia da doença COVID-19 e do processo de recuperação económica e social.
    10 fevereiro 2021

  • Sandra Pereira questiona os Professores Baltazar Nunes e Filipe Froes

    5:25

    Intervenção na Comissão Eventual para o acompanhamento da aplicação das medidas de resposta à pandemia da doença COVID-19 e do processo de recuperação económica e social.
    10 fevereiro 2021

  • Sandra Pereira questiona Eurico Reis

    2:25

    Intervenção no Grupo de Trabalho da Procriação Medicamente Assistida.
    18 março 2021

  • Conversas Fora da Caixa - Temporada 3, Ep. 01

    1:18:33

    As Conversas Fora da Caixa regressam em 2021 com uma nova temporada, que promete continuar a trazer excelentes convidados e conversas acutilantes.

    O Dr. Filipe Froes é Pneumologista e Coordenador do Gabinete de Crise COVID-19 da Ordem dos Médicos. E será o primeiro convidado deste ano, numa conversa que será sobre a vacinação e as medidas de confinamento que serão anunciadas esta semana.

    Não perca a emissão na próxima quinta feira, a partir das 21 horas, no Facebook, Twitter e YouTube. Contamos consigo!

  • Covid-19 - Prof. Filipe Froes - Sociedade Portuguesa Cardiologia

    37:33

    Sabe o que significa COVID-19?

    O que a torna numa doença tão contagiosa?

    O que são as novas variantes?

    Hoje temos nas Conversas de Risco, com a Dra. Mónica Mendes Pedro, o Prof. Filipe Froes, Médico Pneumologista e Intensivista, que nos explica como funciona o vírus que invadiu o planeta no último ano. Uma conversa iluminadora que descontrói termos médicos em conceitos fáceis de compreender para qualquer um.

    Assista à conversa completa

  • 2021 02 10 - Covid-19: Audição Baltazar Nunes, Filipe Froes, António Silva Graça e Germano de Sousa

    2:23:18

    Audição conjunta: Baltazar Nunes, Epidemiologista, Filipe Froes, Coordenador da Comissão de Trabalho de infeciologia respiratória da Sociedade Portuguesa de Pneumologia e Coordenador do Gabinete de Crise da Ordem dos Médicos, António Silva Graça, Infeciologista, Germano de Sousa, Médico Patologista Clínico APDMGP

  • A gestão do Covid 19

    1:16:15

    Debate online A Gestão do Covid 19, promovido pela Oficina da Liberdade. Participam Telmo Azevedo Fernandes, Carlos Guimarães Pinto, Andé Dias e Carlos Menezes Oliveira

  • Conversa Improvável -

    14:35

    No “Deals on Wheels - especial” de hoje vamos falar da parceria entre a Brisa e a Leaseplan.
    Quais as vantagens para o utilizador de automóvel? Venha ouvir Eduardo Ferreira de Lemos, o responsável de estratégia Brisa, e António Oliveira Martins, country manager da Leaseplan.
    Venha daí ????

Shares

x

Check Also

Menu